Clinical Trial Update: Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial investigating decitabine as epigenetic priming with induction chemotherapy in pediatric acute myeloid leukemia; study terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Eisai Inc. | Conditions: Pediatric Acute Myelogenous Leukemia (AML) | Phase 2 | Status: TERMINATED | Results posted: 2022-06-28